Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.

por Eggermont, A. M., Sugarbaker, P. H.
Publicado 1988

What can we learn from phase II adjuvant trials in melanoma?

por Keilholz, U, Suciu, S, Eggermont, A M M
Publicado 2000

Epidemiology of invasive cutaneous melanoma

por MacKie, R. M., Hauschild, A., Eggermont, A. M. M.
Publicado 2009

Staging of cutaneous melanoma

por Mohr, P., Eggermont, A. M. M., Hauschild, A., Buzaid, A.
Publicado 2009

Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2.

por Eggermont, A. M., Steller, E. P., Matthews, W., Sugarbaker, P. H.
Publicado 1987

Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats

por ten Hagen, T L M, Hoving, S, Ambagtsheer, G, van Tiel, S T, Eggermont, A M M
Publicado 2004

Site-specific antitumour effects of 2 pyrimidinone compounds in rats.

por Eggermont, A. M., Marquet, R. L., De Bruin, R. W., Weimar, W., Jeekel, J.
Publicado 1986

Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery

por Brunstein, F, Rens, J, van Tiel, S T, Eggermont, A M M, ten Hagen, T L M
Publicado 2006

Impaired neutralising antibody formation and high transduction efficacy after isolated hepatic perfusion with adenoviral vectors

por van Etten, B, Eggermont, A M M, Ambagtsheer, G, van Tiel, S T, ten Hagen, T L M
Publicado 2004

Isolated Tumor Cells and Long-Term Prognosis of Patients with Melanoma

por van Akkooi, A. C. J., de Wilt, J. H. W., Verhoef, C., Eggermont, A. M. M.
Publicado 2008

Cutaneous Melanoma and Sentinel Lymph Node Biopsy

por van Akkooi, A. C. J., de Wilt, J. H. W., Verhoef, C., Eggermont, A. M. M.
Publicado 2008

Surgery and radiotherapy in the treatment of cutaneous melanoma

por Testori, A., Rutkowski, P., Marsden, J., Bastholt, L., Chiarion-Sileni, V., Hauschild, A., Eggermont, A. M. M.
Publicado 2009

Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

por van Etten, B, ten Hagen, T L M, de Vries, M R, Ambagtsheer, G, Huet, T, Eggermont, A M M
Publicado 2002

Biomarkers in melanoma

por Gogas, H., Eggermont, A. M. M., Hauschild, A., Hersey, P., Mohr, P., Schadendorf, D., Spatz, A., Dummer, R.
Publicado 2009

A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.

por Marinelli, A., van de Velde, C. J., Kuppen, P. J., Franken, H. C., Souverijn, J. H., Eggermont, A. M.
Publicado 1990

Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity

por Seynhaeve, A L B, de Wilt, J H W, van Tiel, S T, Eggermont, A M M, ten Hagen, T L M
Publicado 2002

Surgical management of melanoma: an EORTC Melanoma Group survey

por Testori, A, Soteldo, J, Powell, B, Sales, F, Borgognoni, L, Rutkowski, P, Lejeune, F, van Leeuwen, PAM, Eggermont, A
Publicado 2013

Stromal influences on breast cancer cell growth.

por van Roozendaal, C. E., van Ooijen, B., Klijn, J. G., Claassen, C., Eggermont, A. M., Henzen-Logmans, S. C., Foekens, J. A.
Publicado 1992

Utility of adjuvant systemic therapy in melanoma

por Eggermont, A. M. M., Testori, A., Marsden, J., Hersey, P., Quirt, I., Petrella, T., Gogas, H., MacKie, R. M., Hauschild, A.
Publicado 2009

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.

por Goey, S. H., Eggermont, A. M., Punt, C. J., Slingerland, R., Gratama, J. W., Oosterom, R., Oskam, R., Bolhuis, R. L., Stoter, G.
Publicado 1995